13F filer · CIK 1773206
Integral Health Asset Management, LLC
New York, NY · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$2.5B
+$440.8M vs prior
Positions
92
New / sold out
31 / 29
Added / reduced
23 / 21
Turnover
31.3%
buys $767.9M · sells $723.2M
Top-10 weight
44.8%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | CVSCVS HEALTH CORP | +950,000 | +633.3% | +$98.3M |
| Added | AXSOME THERAPEUTICS INC. | +265,000 | +757.1% | +$64.9M |
| Added | EDWARDS LIFESCIENCES CORP | +455,000 | +267.6% | +$41.2M |
| New | ABBOTT LABORATORIES | +400,000 | – | +$36.3M |
| New | UNITEDHEALTH GROUP INC | +85,000 | – | +$35.3M |
| New | TENET HEALTHCARE CORP | +165,000 | – | +$30.9M |
| Added | QUEST DIAGNOSTICS INC | +140,000 | +233.3% | +$29.7M |
| New | SPYRE THERAPEUTICS INC | +325,000 | – | +$28.9M |
| New | NOVO-NORDISK A S | +600,000 | – | +$28.8M |
| New | IONIS PHARMACEUTICALS INCCALL | +300,000 | – | +$23.8M |
44 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | REVOLUTION MEDICINES INCPUT | -450,000 | -60.0% | $-84.3M |
| Sold out | CYTOKINETICS INCCALL | -1,000,000 | -100.0% | $-65.9M |
| Sold out | ASTRAZENECA PLC | -250,000 | -100.0% | $-49.3M |
| Reduced | BRIGHTSPRING HEALTH SVCS INC | -700,000 | -56.0% | $-48.8M |
| Sold out | REVOLUTION MEDICINES INCCALL | -500,000 | -100.0% | $-48.6M |
| Reduced | REGENERON PHARMACEUTICALS | -45,000 | -52.9% | $-28.1M |
| Sold out | ASCENDIS PHARMA A/S | -115,000 | -100.0% | $-26.3M |
| Reduced | CENTENE CORP DEL | -350,000 | -53.8% | $-22.5M |
| Sold out | FRESENIUS MEDICAL CARE AG | -775,000 | -100.0% | $-17.5M |
| Sold out | INTUITIVE SURGICAL INC | -35,000 | -100.0% | $-16.1M |
40 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INCCOM | 1,500,000 | $280.9M | 11.10% |
| 2 | INSMED INCCOM PAR $.01 | 1,600,000 | $170.6M | 6.74% |
| 3 | CYTOKINETICS INCCOM NEW | 1,600,000 | $136.3M | 5.38% |
| 4 | CVSCVS HEALTH CORP | 1,100,000 | $113.8M | 4.49% |
| 5 | EDGEWISE THERAPEUTICS INCCOM | 2,000,000 | $81.3M | 3.21% |
| 6 | VERA THERAPEUTICS INCCL A | 1,750,000 | $75.1M | 2.97% |
| 7 | AXSOME THERAPEUTICS INC.COM | 300,000 | $73.4M | 2.90% |
| 8 | CARDINAL HEALTH INCCOM | 300,000 | $71.3M | 2.81% |
| 9 | ROIVANT SCIENCES LTDSHS | 2,000,000 | $70.8M | 2.80% |
| 10 | RHYTHM PHARMACEUTICALS INCCOM | 550,000 | $61.1M | 2.41% |
82 more rows. Subscribe for $29/month to see every row, download the data and use the API.